Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

In many prokaryotes, type III clustered regularly interspaced short palindromic repeat (CRISPR)–CRISPR-associated (Cas) systems detect and degrade invasive genetic elements by an RNA-guided, RNA-targeting multisubunit interference complex. The CRISPR-associated protein Csm6 additionally contributes to interference by functioning as a standalone RNase that degrades invader RNA transcripts, but the mechanism linking invader sensing to Csm6 activity is not understood. Here we show that Csm6 proteins are activated through a second messenger generated by the type III interference complex. Upon target RNA binding by the interference complex, its Cas10 subunit converts ATP into a cyclic oligoadenylate product, which allosterically activates Csm6 by binding to its CRISPR-associated Rossmann fold (CARF) domain. CARF domain mutations that abolish allosteric activation inhibit Csm6 activity in vivo, and mutations in the Cas10 Palm domain phenocopy loss of Csm6. Together, these results point to an unprecedented mechanism for regulation of CRISPR interference that bears striking conceptual similarity to oligoadenylate signalling in mammalian innate immunity.

[1]  Luciano A. Marraffini,et al.  Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting , 2014, Nature.

[2]  T. Osawa,et al.  Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex. , 2013, Journal of molecular biology.

[3]  Joshua R. Elmore,et al.  Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system , 2016, Genes & development.

[4]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[5]  Patrice Gouet,et al.  ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..

[6]  Maruf M. U. Ali,et al.  Phosphoregulation of Ire1 RNase splicing activity , 2014, Nature Communications.

[7]  Scott Bailey,et al.  RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex. , 2016, Genes & development.

[8]  L. Aravind,et al.  Comparative genomic analyses reveal a vast, novel network of nucleotide-centric systems in biological conflicts, immunity and signaling , 2015, Nucleic acids research.

[9]  Albert J R Heck,et al.  Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. , 2013, Molecular cell.

[10]  Michael J E Sternberg,et al.  The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.

[11]  M. F. White,et al.  CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems , 2014, Front. Genet..

[12]  Kira S. Makarova,et al.  Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems , 2016, Science.

[13]  Eugene V Koonin,et al.  Diversity, classification and evolution of CRISPR-Cas systems. , 2017, Current opinion in microbiology.

[14]  V. Hornung,et al.  OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids , 2014, Nature Reviews Immunology.

[15]  W. Guo,et al.  Crystal structures of CRISPR-associated Csx3 reveal a manganese-dependent deadenylation exoribonuclease , 2015, RNA biology.

[16]  Luciano A. Marraffini,et al.  Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity , 2016, Cell.

[17]  R. Terns,et al.  The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease , 2016, RNA.

[18]  M. Jinek,et al.  Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6 , 2016, RNA.

[19]  Xu Peng,et al.  A novel interference mechanism by a type IIIB CRISPR‐Cmr module in Sulfolobus , 2013, Molecular microbiology.

[20]  Rotem Sorek,et al.  CRISPR-mediated adaptive immune systems in bacteria and archaea. , 2013, Annual review of biochemistry.

[21]  Stan J. J. Brouns,et al.  Evolution and classification of the CRISPR–Cas systems , 2011, Nature Reviews Microbiology.

[22]  E. Koonin,et al.  Comprehensive analysis of the HEPN superfamily: identification of novel roles in intra-genomic conflicts, defense, pathogenesis and RNA processing , 2013, Biology Direct.

[23]  Luciano A. Marraffini,et al.  Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity , 2015, Cell.

[24]  Luciano A. Marraffini,et al.  Genetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas System , 2013, Journal of bacteriology.

[25]  Eric R Geertsma,et al.  FX cloning: a simple and robust high-throughput cloning method for protein expression. , 2014, Methods in molecular biology.

[26]  K Henrick,et al.  Electronic Reprint Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions , 2022 .

[27]  C. Lawrence,et al.  Recognition of a pseudo-symmetric RNA tetranucleotide by Csx3, a new member of the CRISPR associated Rossmann fold superfamily , 2016, RNA biology.

[28]  Jie Zhou,et al.  Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. , 2013, Chemical Society reviews.

[29]  Jennifer A. Doudna,et al.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection , 2016, Nature.

[30]  R. Terns,et al.  Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex , 2014, Genes & development.

[31]  Sita J. Saunders,et al.  An updated evolutionary classification of CRISPR–Cas systems , 2015, Nature Reviews Microbiology.

[32]  Xu Peng,et al.  CRISPR-Cas type I-A Cascade complex couples viral infection surveillance to host transcriptional regulation in the dependence of Csa3b , 2016, Nucleic acids research.

[33]  J. Tainer,et al.  The structure of the CRISPR-associated protein Csa3 provides insight into the regulation of the CRISPR/Cas system. , 2011, Journal of molecular biology.

[34]  L. Kuo,et al.  Activation of RNase L by 2′,5′-Oligoadenylates , 1997, The Journal of Biological Chemistry.

[35]  M. O'Reilly,et al.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage , 1983, Nature.

[36]  Luciano A. Marraffini,et al.  CRISPR-Cas immunity in prokaryotes , 2015, Nature.

[37]  Wenyan Jiang,et al.  A Ruler Protein in a Complex for Antiviral Defense Determines the Length of Small Interfering CRISPR RNAs , 2013, The Journal of Biological Chemistry.

[38]  Česlovas Venclovas,et al.  Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition. , 2016, Molecular cell.

[39]  Česlovas Venclovas,et al.  Type III CRISPR-Cas Immunity: Major Differences Brushed Aside. , 2017, Trends in microbiology.

[40]  Albert J R Heck,et al.  RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. , 2014, Molecular cell.